Brandon Richland, MD Semaglutide is the generic drug name for Wegovy and Ozempic, which are the most recognized brands used for weight loss treatments
GLP-1 receptors exist throughout the body, not just in the pancreas and hypothalamus, and activating them produces effects that extend far beyond metabolic signaling
Ambos contienen tirzepatide, pero Mounjaro est aprobado para diabetes tipo 2 (mayo 2022) y Zepbound para manejo de peso en adultos con obesidad o sobrepeso con comorbilidades (noviembre 2023)
working closely with your healthcare team is essential for managing side effects effectively
Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for weight management in the UK
Drugs 78(11):11131132 dAquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, et al (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management